Insights from 2024 ASCO® GU Annual Meeting


 

ASCO® GU 2024 Insights: "PemCab Trial - Cabozantinib + Pembro as 1L Therapy for Cisplatin-Ineligible Advanced Urothelial Carcinoma"

140 views
February 6, 2024
Comments 0
Login to view comments. Click here to Login